Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 4, 2026
Accession Number:
0001193125-26-088282
Submission Type:
POS AM
CIK:
0001673772
Company Name:
RAPT Therapeutics, Inc.
File Number:
333-273910